Menlo Park, CA, United States of America

Ronalee Lo Mann


 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ronalee Lo Mann: Innovator in Iontophoretic Drug Delivery Systems

Introduction:

Ronalee Lo Mann is a prominent inventor based in Menlo Park, California, renowned for her innovative contributions to the field of medical technology. Her work focuses on enhancing drug delivery methods, particularly through the use of iontophoretic systems. With a commitment to improving therapeutic techniques, Ronalee has made significant strides in the healthcare sector.

Latest Patents:

Ronalee holds a patent for the "Detection of presence and alignment of a therapeutic agent in an iontophoretic drug delivery device." This groundbreaking patent describes a system designed to test whether an iontophoretic drug delivery device is in the correct state for administering a therapeutic agent into an animal body. Utilizing an electrical characteristic of at least one electrical path linked to an electrode test point, the system determines the readiness of the device. This innovation ensures that the therapeutic agent is accurately positioned concerning the electrodes, ultimately enhancing patient safety and treatment efficacy.

Career Highlights:

Currently, Ronalee Lo Mann is associated with Teva Pharmaceuticals International GmbH, where she applies her expertise in drug delivery technologies. Her role involves extensive research and development aimed at advancing the capabilities of therapeutic devices. With one patent to her name, she has not only contributed to her company but also set benchmarks in the medical device field.

Collaborations:

In her journey, Ronalee has collaborated with notable colleagues such as Jason Clevenger and David Saar. Working alongside talented professionals has enabled her to refine her ideas and integrate diverse insights into her inventiveness, propelling forward the evolution of iontophoretic drug delivery systems.

Conclusion:

Ronalee Lo Mann exemplifies the spirit of innovation in the medical technology sector. Her dedication to improving drug delivery systems through her patented technology showcases her role as a trailblazer in healthcare innovation. As she continues her work at Teva Pharmaceuticals, her contributions will undoubtedly pave the way for future advancements in therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…